Voices
Myeloma Paper of the Day, June 9th Suggested by Robert Orlowski

Myeloma Paper of the Day, June 9th Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Study of AL amyloidosis pts getting ASCT finds benefit for those not in CR after induction but not if in CR, dara + ASCT linked w/ longer TTP, whereas higher BMPC% (>20%) at dx & gain/amp 1q linked with shorter TTP․”

Title: Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis

Authors: Maximilian Steinhardt, Ute Hegenbart, Tamer Hellou, Sara Oubari, Murielle Roussel, Rahel Schwotzer, Francis Buadi, David Dingli, Moritz Binder, Taxiarchis Kourelis, Saurabh Zanwar, Max Rieger, Caroline Morbach, Vladimir Cejka, Bernhard Gerber, Stefan Störk, Hermann Einsele, Shaji Kumar, Morie Gertz, Alexander Carpinteiro, Martin Kortum, Eli Muchtar, Angela Dispenzieri, Stefan Schönland

You can read the Full Article on American Journal of Hematology.

Myeloma Paper of the Day, June 9th Suggested by Robert Orlowski

You can find other articles featuring Robert Orlowski on OncoDaily.

Alexander Carpinteiro American Journal of Hematology Angela Dispenzieri Bernhard Gerber cancer Caroline Morbach David Dingli Eli Muchtar Francis Buadi Hermann Einsele Martin Kortüm Max Rieger Maximilian Steinhardt Morie Gertz Moritz Binder Murielle Roussel Myeloma Paper of the Day OncoDaily Oncology Rahel Schwotzer Robert Orlowski Sara Oubari Saurabh Zanwar Shaji Kumar Stefan Schönland Stefan Störk Tamer Hellou Taxiarchis Kourelis Ute Hegenbart Vladimir Cejka